Company Orexigen Therapeutics, Inc. Nasdaq
Equities
US6861643020
Biotechnology & Medical Research
Business Summary
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,887,033 | 18,887,033 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Orexigen Therapeutics, Inc.
3344 North Torrey Pines Court Suite 200
92037, La Jolla
+858-875-8600
http://www.orexigen.com![address Orexigen Therapeutics, Inc.](https://cdn.zonebourse.com/static/address/30049593.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |